Response to desmopressin in type IID von Willebrand's disease.
Dominant transmission of a variant of von Willebrand's disease (vWD) with aberrant polymerization of von Willebrand factor (vWF) has been identified in a Scottish family. Multimer analysis of plasma vWF from the propositus and her father revealed an identical pattern to that previously reported in families designated as type IID vWD. There is loss of the larger multimers and presence of an intermediate subsidiary band not seen in normal subjects or other vWD variants. Platelet/vWF interaction induced by ristocetin is not enhanced in these cases and the platelet vWF shows the same aberrant multimer pattern as plasma vWF. DDAVP infusion in two affected members of the Scottish family and in one of the index cases produced a rise in plasma vWF antigen and factor VIII. Higher molecular weight vWF multimers appeared transiently after infusion of desmopressin (1-deamino-8-D-arginine vasopressin, abbreviated DDAVP) coincident with shortening of the bleeding time. The platelet counts did not change after the DDAVP infusions. DDAVP should be considered for management of bleeding in this variant of von Willebrand's disease.
Thomas
N
N
Academic Department of Haematology, Royal Free Hospital, London, UK.
O'Callaghan
U
U
Lowe
G D
GD
Olszynski
V
V
Kernoff
P B
PB
Abildgaard
C F
CF
Tuddenham
E G
EG
D000328:Adult; D001792:Blood Platelets / Q000032:analysis; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D046911:Macromolecular Substances; D008297:Male; D014842:von Willebrand Diseases / Q000097:blood / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000032:analysis*
D046911:Macromolecular Substances; D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin